Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiejie Jin
Observed names:
J Jin,
Yanong Wang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Chinese Academy of Medical Sciences & Peking Union Medical College,
Fudan University,
Fudan University Shanghai Cancer Center,
Cancer Hospital of Chinese Academy of Medical Sciences
ORCID:
0000-0002-7405-5229
Observed ORCID:
0000-0002-7405-5229
OpenAlex ID:
A5102001493
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
2023
·
Jian Li
, Jun Zhang
, et al.
·
European Journal of Cancer
·
16
Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China
2026
·
Xiaowen Liu
, Jiejie Jin
, et al.
·
癌症:英文版
·
3
PDF
[A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node].
2020
·
Z B Yang
, Z Huang
, et al.
·
PubMed
·
3
Long‐term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial
2025
·
Jun Zhang
, Yanqiao Zhang
, et al.
·
Cancer
Show more works
View as search
Works count:
4
Citation count:
21
H-index:
3
I10-index:
1
Year
Topic
Type